Perrigo Company plc Proceeds from (Repayments of) Short-term Debt
Perrigo Company plc (PRGO) reported Proceeds from (Repayments of) Short-term Debt of -$2.10 million for the 3-month period ending 2014-09-27, per its 8-K filed 2014-11-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2014-11-20
- Perrigo Company plc proceeds from (repayments of) short-term debt for the quarter ending 2014-09-27 was -$2.10M, a 290.91% decline year-over-year.
- Perrigo Company plc proceeds from (repayments of) short-term debt for the quarter ending 2014-06-28 was $2.00M, a 233.33% increase year-over-year.
- Perrigo Company plc proceeds from (repayments of) short-term debt for the quarter ending 2014-03-29 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc proceeds from (repayments of) short-term debt for the quarter ending 2013-12-28 was -$6.10M.
- Perrigo Company plc proceeds from (repayments of) short-term debt for fiscal 2014 was -$3.00M, a 160.00% decline from fiscal 2013.
- Perrigo Company plc proceeds from (repayments of) short-term debt for fiscal 2013 was $5.00M.
- Perrigo Company plc proceeds from (repayments of) short-term debt for fiscal 2012 was -$2.70M.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|
| 2014-09-27 | -$2.10M 8-K · filed 2014-11-20 | -$100.00K derived: sum of 2 quarters · filed 2014-11-20 | -$100.00K derived: sum of 3 quarters · filed 2014-11-20 | -$6.20M derived: sum of 4 quarters · filed 2014-11-20 |
| 2014-06-28 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-14 | $2.00M derived: sum of 2 quarters · filed 2014-08-14 | -$4.10M derived: sum of 3 quarters · filed 2014-08-14 | -$3.00M 10-K · filed 2014-08-14 |
| 2014-03-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | -$6.10M derived: sum of 2 quarters · filed 2014-05-07 | -$5.00M 10-Q · filed 2014-05-07 | -$4.40M derived: sum of 4 quarters · filed 2014-11-20 |
| 2013-12-28 | -$6.10M derived: 10-Q 6 month − 8-K 3 month · filed 2014-02-06 | -$5.00M 10-Q · filed 2014-02-06 | -$4.40M derived: sum of 3 quarters · filed 2014-11-20 | -$2.60M derived: sum of 4 quarters · filed 2014-11-20 |
| 2013-09-28 | $1.10M 8-K · filed 2014-11-20 | $1.70M derived: sum of 2 quarters · filed 2014-11-20 | $3.50M derived: sum of 3 quarters · filed 2014-11-20 | |
| 2013-06-29 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-14 | $2.40M derived: sum of 2 quarters · filed 2014-08-14 | $5.00M 10-K · filed 2014-08-14 | |
| 2013-03-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $4.40M 10-Q · filed 2014-05-07 | ||
| 2012-12-29 | $2.60M 10-Q · filed 2014-02-06 | |||
| 2012-06-30 | -$2.70M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |